Is the Meibopatch Heated Pad Useful in Treating Patients with Meibomian Gland-Related Dry Eye Disease? – Assessing Tolerability, Acceptance, and Effectiveness

The results suggest that Meibopatch represents a safe therapeutic option for managing DES. However, the controversy arises from the incongruence between the substantial reduction in symptoms noted from the OSDI scores and the reported patient outcomes regarding satisfaction and effectiveness. Future efforts should focus on validating the OSDI in blepharitis patients and establishing patient-centered outcomes in the realm of DES.